Drugs & Targets MD Anderson and Allogene Therapeutics collaborate to advance allogeneic CAR T therapy October 16, 2020Vol.46 No.39
Drugs & TargetsFree Opdivo + Yervoy receive FDA approval in mesothelioma indication October 09, 2020Vol.46 No.38
Drugs & TargetsFree Regeneron asks FDA for emergency clearance for COVID-19 therapy October 09, 2020Vol.46 No.38
Drugs & TargetsFree FDA issues draft guidance that encourages inclusion of premenopausal women in breast cancer clinical trials October 09, 2020Vol.46 No.38
Drugs & TargetsFree Innova Therapeutics receives Rare Pediatric Disease Designation from FDA for IVT-8086 for Osteosarcoma October 02, 2020Vol.46 No.37
Drugs & TargetsFree Celyad Oncology collaborates with MSD to evaluate CYAD-101 with Keytruda in microsatellite stable mCRC October 02, 2020Vol.46 No.37
Drugs & TargetsFree University of Illinois scientists enter licensing deal with Bayer, Systems Oncology October 02, 2020Vol.46 No.37
Drugs & TargetsFree Elevation Oncology and US Oncology Research collaborate to expand genomic testing of solid tumors October 02, 2020Vol.46 No.37
Drugs & Targets Expanded access eRequest app allows physicians to submit EA requests online September 25, 2020Vol.46 No.36
